Clinical trial
A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients…
NCT00424931 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00424931 |
|---|---|
| Title | A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy |
| Official title | A Phase II Randomized, Double-blind, Double-dummy, Placebo and Comparator-controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of a Single Dose of JNJ-17216498 Administered to Subjects With Narcolepsy. |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Narcolepsy |
| Intervention type | Drug |
| Interventions | JNJ-17216498, Modafinil |
| Enrollment | 16 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 22, 2007 |
| Last update posted | May 23, 2014 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: